Kevin Michael O'Neill - 02 Mar 2026 Form 4 Insider Report for GE HealthCare Technologies Inc. (GEHC)

Reporting relationship: CEO, PDx
Issuer ticker: GEHC
Reported as of: 02 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Mar 2026, 16:24:50 UTC
Prior SEC filing: 17 Feb 2026
Next SEC filing: 04 Sep 2026
Source filing: View source filing
Reporting owner signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact

Filing notes and source

Key filing fact

Kevin Michael O'Neill filed Form 4 for GE HealthCare Technologies Inc. (GEHC) on 04 Mar 2026.

Key facts

This page summarizes Kevin Michael O'Neill's Form 4 filing for GE HealthCare Technologies Inc. (GEHC).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Mar 2026, 16:24.

Change

Previous filing in this sequence was filed on 17 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001951605 Primary reporting owner

O'Neill Kevin Michael

Relationship: CEO, PDx
Address: 500 W. MONROE STREET, CHICAGO
Signature: /s/ Frank R. Jimenez, General Counsel and Corporate Secretary, as attorney-in-fact
Signature date: 04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GEHC transaction

Common Stock, par value $0.01 per share

Award

Transaction value
Shares: +6,549
Change %: +25%
Price: $0.000000^*
Shares after: 32,744
Date: 02 Mar 2026
Ownership: Direct
Footnotes: F1, F2

GEHC holding

Common Stock, par value $0.01 per share

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 59
Date: 02 Mar 2026
Ownership: By share incentive plan trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GEHC transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +17,218
Change %
Price: $0.000000^*
Shares after: 17,218
Date: 02 Mar 2026
Ownership: Direct
Underlying class: Common Stock, par value $0.01 per share
Underlying amount: 17,218
Exercise price: $80.16
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents the right to receive, at settlement, one share of GE HealthCare Technologies Inc. ("GE HealthCare") common stock.

Footnote F2

Award of restricted stock units with respect to GE HealthCare common stock, of which 33% will vest on September 2, 2027, 33% will vest on September 2, 2028, and 34% will vest on September 2, 2029.

Footnote F3

Award of an employee stock option with respect to GE HealthCare common stock, of which 33% will become exercisable on September 2, 2027, 33% will become exercisable on September 2, 2028, and 34% will become exercisable on September 2, 2029.